S
ince shortly after the discovery of IgD, its main role in the immune system has been believed to be as a BCR (1-6) (for review see Ref. 7) . IgD is not appreciably expressed by early developing B lymphocytes of the bone marrow (BM) or end stage Ab-secreting plasma cells. Instead, through alternative RNA splicing of primary IgH locus transcripts (8, 9) IgD is coexpressed with IgM as a membrane Ig (mIg) by most mature, quiescent B cells in mammals (1, 2, 10) and most other vertebrate species (11) (12) (13) (14) [although not in rabbits and birds (15) (16) (17) ]. Alternative RNA splicing ensures that on any given cell, the Ag specificity of IgM and IgD molecules is identical (18) (19) (20) (21) and allows coexpression of IgD and IgM at different relative abundances (22, 23) . This ability of IgD expression to be regulated by RNA splicing is evolutionarily ancient and probably predates the process of class switching (14) .
Surface expression of IgD varies with B cell subset. It is highest in long-lived recirculating B cells that are abundant in follicles of the spleen (SP) and lymph nodes (LNs), on which mIgD levels can exceed those of mIgM by 10-fold (24) . IgD is expressed at lower levels on B-1 cells, which are abundant in the peritoneal cavity (PC), lamina propria, and pleural tissues (25) , and on distinct B cells of the splenic marginal zone (MZ) (26) . IgD is also expressed on many recently generated semimature transitional B cells found in the SP and BM, most of which are short lived and express CD93 (27) (28) (29) (30) (31) . B cells initially transitioning from the BM to the SP are CD21 2 CD23 2 IgD lo/2 and are referred to as transitional B cell population 1 (T1) cells. Upon maturation to the T2 stage, all three surface molecules are upregulated along with CD62L. T3 and naive follicular (B-2) cells continue to retain high surface IgD (sIgD) expression while downregulating their sIgM (31) . IgD expression is therefore an important marker for B cell developmental stage and maturation. However, IgM and IgD can also be functionally redundant. For example, in IgM 2/2 mice and in IgD transgenic (Tg) mice, IgD can substitute for IgM in promoting early B cell development (32, 33) . Immature B cells and B cells from fetal and neonatal mice express exclusively IgM (1, 2, 34) and tend to be more susceptible to immune tolerance than are more mature cells that coexpress IgD (35, 36) , correlations that prompted the hypothesis that IgD expression could protect B cells from immune tolerance (37, 38) . However, mature IgD + B cells encountering foreign or self-ligands can be rendered tolerant by clonal elimination or functional inactivation (33, (39) (40) (41) (42) . Moreover, functionally hyporesponsive anergic B cells are characterized by high levels of mIgD combined with low levels of mIgM and generally turn over rapidly when competing nontolerant B cells are present (43) (44) (45) . On the other hand, IgD expression is correlated with developmental maturation and the loss of the ability of B cells to undergo self-Ag-induced receptor editing (46, 47) . However, transitional cells might retain the capacity to edit given the appropriate microenvironment (48, 49) .
Like mIgM, mIgD can transmit signals through the associated signal transducers Ig-a/b (CD79a/b) (50) (51) (52) , triggering a tyrosine kinase cascade and the activation of additional signaling pathways. Early biochemical changes triggered by IgM and IgD in mature B cells are biochemically similar, although signaling through IgD may be more prolonged (53) . However, upon activation by Ag, IgD expression on B cells is lost (54) (55) (56) . With rare exceptions, IgD is not expressed by plasma cells, although the secretory domain of IgD is intact and conserved in most species studied. IgD is secreted at relatively high levels in rare inflammatory diseases, such as mevalonate kinase deficiency (57) . Rare cells or tumors with dedicated IgD secretion can be found that have undergone a recombination event similar to classical switch recombination (58) . In humans, a subset of IgD classswitched cells with unique properties exists (59) , and it has been suggested that basophils carry an Fc receptor for IgD (60) . However, IgD-deficient mice have been generated and shown to have only subtle defects, mainly in the kinetics of T celldependent (TD) Ab responses (61, 62) .
We recently developed a custom superantigen technology based on the expression of membrane tethered single-chain Abs reactive to Ab constant regions (63) (64) (65) . The goal of the current study was to assess the ability of an IgD-reactive superantigen expressed as a ubiquitously expressed transgene in mice to promote B cell tolerance and to alter B cell development and function. These studies were carried out with a view to establishing more precisely the cell lineage and precursor/product relationships among B cell subsets found in the secondary lymphoid tissues and their modes of tolerance induction.
Materials and Methods

IgD a -macroself construct
The transgene encoding IgD a -macroself Ag was generated based on a plasmid template described for Igk-macroself (63) . Total RNA from AMS9.1 hybridoma was isolated using Trizol (Invitrogen, Carlsbad, CA) according to manufacturer's instruction. V L and V H cDNA sequences were obtained by 59 RACE (Ambion, Austin, TX) using C k and IgG2b antisense primers and cloned into Zero Blunt TOPO vector using methods suggested by the manufacturer (Invitrogen). Using the Igk-macroself construct as template, a cDNA fragment containing part of the ubiquitin promoter (pUb) and the 59 end of the V L was generated by PCR using pUb F and iLAMS9 R primers. From the TOPO vector containing the V L cDNA, the V L fragment was reamplified using extended primers (AMS9V L F and AMS9V L R) that contained the antisense sequence of the linker at its 39 end. Similarly, the V H fragment was reamplified using primers (AMS9V H F and AMS9V H R) that contained sequence for the linker at its 59 end and part of rat IgG1 Fc at its 39. PCRs for all three fragments were performed for 25 cycles using Accuprime Pfx (Invitrogen). Melting (94˚C), annealing (55˚C), and elongation (68˚C) times were 45 s each. Subsequently, a long insert containing all three fragments was generated by nested PCR using the pUb F and AMS9V H R primers. A total of 25 cycles were performed using the following conditions: melting (94˚C, 1 min), annealing (50˚C, 1 min), and elongation (68˚C, 1 min). The insert was subsequently gelpurified, digested with SpeI and XmaI, and cloned into the previously described Igk-macroself construct (after removing the anti-Igk cDNA insert by SpeI and XmaI digestion). After linearization by NotI digestion, plasmid was sent to The Scripps Research Institute Transgenic Core (La Jolla, CA) for pronuclei injection. Primer sequences used are as follows: Ck antisense (59-ctg ctc act gga tgg tgg gaa gat gg-39); IgG2b antisense (59-gga cag gga tcc aga gtt cca agt-39); pUb F (59-ttt tct ccg tcg cag gac gca ggg ttc ggg-39); iLAMS9 R (59-atc aca atg tcc tct gca cag gca cct gta ata att aat agg c-39); AMS9 V L F (59-tac agg tgc cTgc aga gga cat tgt gat gtc aca gtc tcc ctc ctc cct ggc tgt gtc-39); AMS9 V L R (59-cct ccc gag cca ccg cct ccg ctg cct ccg cct ccc cgt tct att tcc aac ttt gtc ccc g-39); AMS9 V H F (59-gca gcg gag gcg gtg gct cgg gag gcg gag gct cgc agg tgc agc tga agg agt cag gac ctg gc-39); and AMS9 V H R (59-atc acc tcc cgg gtt tct ggg ggc tgt tgt ttc agc tga gga gac ggt gac cgc ggt ccc tgt gcc-39).
IgD a -macroself mice
Animal studies have been reviewed and approved by the The Scripps Research Institute institutional review committee. All IgD a -macroself Tg mice described in this work had been bred and maintained on C57BL/6 background congenic for IgH a/a alleles (B6.Cg-Igh a Thy1 a Gpi1 a /J, stock number 001317, JAX) for at least eight generations. In some experiments, they were also bred to overexpress BAFF-R but retain IgH a/a alleles. BAFF Tg mice have been described (66) . To genotype for the presence of transgene in each breeding, 35 cycles of PCR were performed using AMS9.1 V L CDR3 S (59-cca aca atc tta taa tct att ca-39) and AMS9.1 V H CDR3 AS (59-cag aca tcg aag tac cag taa t-39) primers and the following conditions: melting (94˚C), annealing (58˚C), and elongation (72˚C) for 40 s each.
BM and SP cell transfers
In all BM transfer experiments, each mouse host was lethally irradiated at 1000 Rad 1 d prior to receiving i.v. 10 7 BM cells, which were isolated from both upper and lower leg bones of donors using standard protocols. Donor mice were either IgH a/a C57BL/6 congenic mice (described above) or Bcl2 Tg (67) bred onto IgH a/a C57BL/6 congenic background. In splenic transfer experiments, total SP cells were isolated from either non-Tg or IgD a -macroself mice by standard procedures. Subsequently, 3 3 10 7 total SP cells were injected i.v. into nonirradiated IgH a/a congenic mice. Because all donor and recipient mice had been crossed onto C57BL/6 background for at least eight generations, no depletion of donor T cells was performed. I.v. injections were performed retro-orbitally.
Flow cytometry analyses
Flow cytometric analyses for surface markers were performed using standard protocols. Intracellular proteins were stained for by using Cytofix/ Cytoperm Kit (BD Biosciences, San Jose, CA) according to manufacturer's recommendations. The following Abs were used at 1:200 in all experiments described: B220 (RA3-6B2; allophycocyanin/Alexa 750; eBioscience, San Diego, CA); CD19 (1D3; PE/Cy7; eBioscience); CD21 (7E9;  FITC 6 cells (in 200 ml) for both surface and intracellular stains. To stain for intracellular IgG, FITClabeled mAbs against each isotype purchased from BD Biosciences (IgG1, A85-1; IgG2a, R19-15; IgG2b, R12-3; and IgG3, R40-82) were mixed and used at 0.15 mg each per 2 3 10 6 cells in 200 ml. To gate out most T and myeloid cells, most flow analyses included a dump Ab mixture consisting of PerCP/Cy5.5-labeled Abs against CD4 (RM4-5), CD8 (53-6.7), Gr-1 (RB6-8C5), and F4/80 (BM8) (all purchased from Biolegend), also used at 1:200 dilution each. All samples were read on an LSR-II instrument (BD Biosciences) and analyzed using the FlowJo program (Tree Star, Ashland, OR). Mean fluorescence intensity values given were calculated by geometric means of the indicated fluorophore staining of the gated cells.
BrdU labeling analyses
All mice were initially injected i.p. with 1 mg/mouse of BrdU (SigmaAldrich, St. Louis, MO) in PBS and immediately placed on drinking water containing 1 mg/ml BrdU for 7 d. Groups of three mice per time point were sacrificed on days 0, 1, 2, 4, and 7. Total cells harvested from their BM and SPs were subjected to intracellular BrdU staining (BD Biosciences) per manufacturer's instruction. Surface staining was performed using the following Abs: CD93-PE (AA4.1, eBioscience); CD23-PE/Cy7 (B3B4, eBioscience); CD21-allophycocyanin (7E9, Biolegend); B220-allophycocyanin/Alexa 750 (RA3-6B2, eBioscience); and PerCP/Cy5.5-labeled dump Ab mixture (see above). Intracellular staining of IgM using PB-labeled clone M41 mAb was performed along with BrdU-FITC (BD Biosciences).
In vitro stimulation for phospho-protein Western analyses
Total B cells were purified from pooled mouse SPs by CD4/CD43-negative selection using the B Cell Isolation Kit (Miltenyi Biotec, Auburn, CA) per the manufacturer's instruction. For Western analyses of phospho-protein levels, purified B cells were resuspended at 10 7 cells/ml in HBSS buffer without supplement, prewarmed to 37˚C in water bath for ∼10 min, and then stimulated for 10 min with 20 mg/ml of goat F(ab9) 2 anti-mouse IgM (Jackson ImmunoResearch Laboratories, West Grove, PA). Pelleted cells were lysed in (100 ml per 10 7 cells) TBS buffer containing 1% Nonidet P-40, Complete EDTA-Free Protease Inhibitor Cocktail (Roche Applied Science, Indianapolis, IN), 5 mM EDTA, 10 mM NaF, and 1 mM Na 3 VO 4 . After removal of insoluble cellular debris by centrifugation, 10 ml each lysate was run in 4-12% NuPAGE gels (Invitrogen). A total of 0.2 mm nitrocellulose membranes (Bio-Rad, Hercules, CA) were used for all Western blotting analyses. The following primary Abs were used at the indicated concentrations, diluted in TBST (TBS plus 0.1% Tween-20) containing either 5% milk or 1% BSA: anti-pTyr (4G10, 1:1000 in milk; Millipore, Bedford, MA), anti-GAPDH (6C5, 1:10,000 in milk; Millipore), anti-pTyr531 CD19 (1:1000 in milk; Cell Signaling Technology, Beverly, MA), rabbit serum anti-total CD19 (1:1000 in milk; generous gift from Dr. J. Cambier at National Jewish Health, Denver, CO), rabbit anti-pERK1/ 2 mAb (197G2, 1:1000 in BSA; Cell Signaling Technology), and rabbit anti-total ERK1/2 pAb (1:1000 in BSA; Cell Signaling Technology). All HRP-conjugated secondary polyclonal Abs were purchased from Jackson ImmunoResearch Laboratories and used at 1:30,000 diluted in TBST plus 5% milk. Signals were developed using SuperSignal West Pico Chemiluminescent Substrate (Pierce, Rockford, IL). To strip blots for reprobing, membranes were incubated at 65˚C with gentle agitation for 15-20 min in TBS buffer (pH 2.3).
In vitro proliferation assays
Two-fold serial dilutions of goat F(ab9) 2 anti-mouse IgM (Jackson ImmunoResearch Laboratories) or LPS (055:B5, Sigma-Aldrich) in media (DMEM containing 10% FBS, 55 mM 2-ME, L-glutamine, and penicillinstreptomycin) were prepared in 96-well plates (100 ml/well). B cells, purified from pooled mouse SPs using a B Cell Isolation Kit (Miltenyi Biotec), were resuspended at 2 3 10 6 cells/ml in media and subsequently added into each well (100 ml/well). After ∼24 h of stimulation, 1 mCi of [ 3 H]thymidine (GE Healthcare, Piscataway, NJ) was added per well. Cells were allowed to label for ∼15 h prior to harvest for scintillation counts. All treatments were done in triplicate.
Ca
2+ flux assays ). A total of 8 3 10 6 SP cells were then preincubated with 500 ml Fluo-4 NW reagent (Invitrogen), 5 mg Fc Block (2.4G2; BD Biosciences), and 1 mg each PerCP-Cy5.5-labeled CD4 and CD8 (RM4-5 and 53-6.7; Biolegend) for 30 min at 37˚C, followed by another 30 min at room temperature. Aliquots of 4 3 10 6 cells (0.5 ml) were then stimulated at room temperature with 10 or 40 mg/ml goat F(ab9) 2 anti-mouse IgM (Jackson ImmunoResearch Laboratories). Ca 2+ signals were recorded for 200 s, gating on CD4/CD8 double-negative cells.
Quantitative RT-PCR
B cells were purified from pooled SPs or BM using B Cell Isolation Kit (Miltenyi Biotec), and their total RNA was isolated using Trizol Reagent (Invitrogen) per kit instructions. After DNase-treatment (Ambion), 4 mg total RNA was used to synthesize first-strand cDNA from random hexamers using Transcriptor First Strand cDNA Synthesis Kit (Roche Applied Science) according to the manufacturer's recommendations. PCRs were performed using SYBR GreenER qPCR Supermix (Invitrogen) and analyzed on the 7900HT Fast Real-Time PCR System (Applied Biosystems, Foster City, CA). Annealing temperature per cycle was set to 60˚C. Quantifications of RAG1 and RAG2 were normalized with concomitant amplifications of b-actin cDNA in each triplicate sample. The following primers were used: RAG1 F (59-gga ggc ctg tgg agc aag gta g-39); RAG1 R (59-gtt ctg acc acc agg ctt ctc t-39); RAG2 F (59-ccc agt gca tgg att tgg aag aac-39); RAG2 R (59-gga gtt tgc aat gct ctt gct atc tg-39); b-actin F (59-caa ccgt gaa aag atg acc cag a-39); and b-actin R (59-cac agc ctg gat ggc tac gta c-39).
Serum Ig ELISAs
Nunc Maxisorp plates (Nunc, Roskilde, Denmark) were coated with 2 mg/ ml rat IgG-adsorbed donkey anti-mouse IgG (H+L) (Jackson ImmunoResearch Laboratories) overnight at room temperature, blocked with 1% BSA in TBST (ELISA buffer) for 1 h, and incubated for 1 h with mouse sera diluted in ELISA buffer. The following biotinylated anti-mouse Abs were used at 0.25 mg/ml in ELISA buffer for detection: IgM (M41), IgG1 (A85-1; BD Biosciences), IgG2a (RMG2a-62; Biolegend), IgG2b (clone R12-3; BD Biosciences), IgG3 (R40-82; BD Biosciences), IgA (C10-1; BD Biosciences), and IgE (R35-72; BD Biosciences). Streptavidin-HRP (BD Biosciences) diluted at 10 23 in ELISA buffer was used to report signals using 1-Step Ultra-TMB Substrate (Pierce) per the manufacturer's instructions. All wells were washed 43 with TBST in between steps. Signals were recorded at 450 nm using VersaMax microplate reader (Molecular Devices, Sunnyvale, CA).
TD and T cell-independent anti-TNP responses
IgD a -macroself and non-Tg littermates were bled on day 0 prior to receiving i.p. 20 mg TNP-Ficoll in PBS or 100 mg trinitrophenol-hemocyanin (TNP-Hy) in Imject Alum adjuvant (Pierce) for subsequent measurements of their T cell-independent and TD responses, respectively. Mice were bled at 7-d intervals. To assess memory responses, the latter group of mice received a secondary challenge of 100 mg TNP-Hy in PBS i.p. on day 44. Sera were collected prior to secondary challenge and 7 d later on day 51. To measure anti-TNP responses by ELISA, Nunc Maxisorp plates (Nunc) were coated with 10 mg/ml of TNP 20 -BSA in PBS overnight, blocked with ELISA buffer for 1 h, and incubated with sera serially diluted 23 in ELISA buffer for 1 to 2 h. All subsequent detection and reporting steps were performed as described above for isotype ELISAs. Response titer at each time point per mouse was defined as the theoretical factor of serum dilution required to achieve half-maximum OD of the assay (normally at values of 1.6-1.9), extrapolated from four-parameter plots.
Results
Generation of IgD a -macroself Tg mice
To assess the in vivo effects of the expression of an IgD-reactive superantigen, a membrane tethered single-chain Ab gene was engineered from the variable H and L regions of anti-IgD a hybridoma AMS9.1 (68) using previously described methods (63) (Supplemental Fig. 1 ). Tg mice that ubiquitously expressed this construct were generated (and are called IgD a -macroself mice hereafter). Three lines with high-, intermediate-, or low-level expression were selected for further study. As the phenotypes of these mice were virtually identical, most data shown in this study involve studies carried out with mice carrying an intermediate level of macroself expression (line #16). All IgD a -macroself mice subsequently analyzed had been bred onto the C57BL/6 background congenic for the IgH a allele for at least eight generations.
Altered mature B cell subsets in IgD a -macroself mice
Flow cytometry analysis was used to assess the effect of superantigen expression on the numbers of B cells in different tissues. Lethally irradiated IgD a -macroself mice were reconstituted with IgH a BM, and their B cell development was compared with that of the similarly treated non-Tg littermates. Initial analysis was carried out with CD19/B220 costaining, which identifies virtually all B cells and can reveal distinct subsets (Fig. 1A , Supplemental Table I ). As expected, no significant changes were seen in immature BM B cells. By contrast, recirculating mature B-2 cells in the BM were virtually absent. This was similarly reflected by the ∼96% reduction in total B cell numbers in the LNs, where the most developmentally mature recirculating B-2 cells normally reside. In the SP, B cell percentages were reduced by .90%. A more detailed analysis for the two major mature B cell subsets in this compartment revealed that B-2 cells bearing the CD23 + CD93
2 B220 + surface phenotype were severely reduced in frequency and number (Fig. 1B, 1E ). However, CD21
hi CD1d hi B220
+ MZ B cells of CD93 2 mature phenotype were clearly present, albeit at only ,15% of normal numbers (Fig. 1C, 1E , Supplemental Table I ). In the peritoneum, total B cell numbers were also reduced although a significant number of CD19 hi B220 lo B cells still remained. These cells were confirmed to be B-1 by CD43 marker expression (Fig. 1D) , suggesting that B-1 cells could still be reconstituted in IgD a -macroself mice by adult BM. Surface IgM + B cells were clearly present in all lymphoid organs tested (Supplemental Fig. 2A ). However, surface IgD expression (measured using an Ab that is not affected by AMS9.1 binding) was
The Journal of Immunologyundetectable on these cells (Supplemental Fig. 2B ). These alterations in B cell development were reproducible in nonirradiated IgD a -macroself mice bred onto a C57BL/6 background homozygously congenic for the IgH a allele, except that normal numbers of B-1 cells were present in the peritoneum (Supplemental Fig. 3 and data not shown). Thus, presence of the IgD a -macroself Ag impaired development of all three mature B cell subsets, although B-1 cell numbers could reach the normal range in intact IgH a mice carrying the macroself Ag.
Developmental block at transitional B cell stages
To determine where developmental block occurred in IgD a -macroself mice, B cells were evaluated for expression of maturation markers. Development of mature B cells in the periphery is thought to occur via two cellular pathways, one in the BM and a second in the SP (69, 70) . Recently formed CD23 + CD93 + T2-like B cells in the BM of IgD a -macroself mice did not appear significantly different from those of non-Tg littermates, either quantitatively or phenotypically ( Fig. 2A, 2D) . Similarly, the number of CD21 2 CD23 2 CD93 + T1 cells in the SP appeared normal (Fig. 2B, 2D ). However, in contrast to the T2-like cells in the BM, the numbers of CD23 + CD93 + transitional B cells in the SP were severely reduced (Fig. 2C, 2D CD23 expression (Fig. 2B, 2C , lower panels). These IgM lo cells expressed highly elevated levels of I-A (MHC class II [MHC II]), a prominent feature of activated B cells (Fig. 3B, 3C ). When isolated from SPs of BM-reconstituted IgD a -macroself mice and cultured for ∼17 h in medium alone, virtually all B cells expressed elevated levels of I-A and CD86 (Supplemental Fig. 4C + anergic T3 population of non-Tg mice as defined by Merrell et al. (71) (Fig. 3B, middle right  panel) . By contrast, I-A expression was not significantly elevated on MZ B cells of Tg mice and only slightly elevated on B-1 cells, suggesting that the majority of these cells were not activated. Thus, the IgD + transitional population appeared to mainly die rapidly subsequent to abortive activation, whereas remaining MZ and B-1 populations appeared stable and more quiescent. (Fig. 4A) . One of these bands proved to be CD19, which was poorly phosphorylated at Tyr531 in IgD a -macroself B cells; however, total CD19 levels of these cells were also reduced. -macroself mice, including reduced CD19 Tyr531 phosphorylation and total CD19 expression, suggesting that they are common characteristics of immature B cells (Fig. 4A) .
Another hallmark of B cell anergy is a reduced Ca 2+ response to BCR cross-linking, but IgD a -macroself B cells appeared to induce a normal Ca 2+ flux upon BCR cross-linking (Fig. 4B) . By contrast, their proliferative responses to all concentrations of anti-IgM tested were severely reduced (Fig. 4C, left panel) . B cells in some models of anergy have also been reported to exhibit reduced responsiveness to LPS (75) . However, this was not the case with B cells from IgD a -macroself mice either, as their responses to LPS were comparable to those of wild-type B cells (Fig. 4C, right  panel) . Although already expressing higher levels of I-A and CD86 than non-Tg B cells when cultured in medium alone, B cells isolated from IgD a -macroself mice failed to upregulate CD86 to the extent of non-Tg B cells upon IgM cross-linking, but did fully upregulate I-A (Supplemental Fig. 4C ). Altogether, these observations suggest that B cells from IgD a -macroself mice displayed a phenotype resembling immature non-Tg B cells rather than tolerized anergic cells, with the exception that they expressed higher levels of the activation markers CD86 and I-A.
Altered L chain repertoire, but lack of peripheral receptor editing
To determine if receptor editing actively occurred in peripheral B cells of IgD a -macroself mice, we assessed L chain isotype usage and RAG expression. Increased l-chain usage often correlates with receptor editing (76) . In BM, l versus k usages were not significantly different between the IgM + immature B cell populations of non-Tg and IgD a -macroself mice (Fig. 5A, 5E ). l L chain representation, however, was significantly increased in total splenic B cells of IgD a -macroself mice (Fig. 5B, 5E ). Mature peritoneal B-1 and splenic MZ B cells also had comparably increased usage of l-chain (Fig. 5C-E) . If receptor editing was responsible for increased l usage, we predicted that increases in RAG1 and RAG2 expression would be apparent in splenic B cells. Quantitative RT-PCR analyses were performed on splenic B cells purified by CD4/CD43-negative selection, revealing that (Fig. 5F ). Although this level was slightly higher than that found in non-Tg B cells, it likely reflected a higher proportion of immature cells in the population because this value was less than that found in non-Tg BAFF 2/2 splenic B cells. Thus, induction of RAG-mediated L chain editing in SPs of IgD a -macroself mice was unlikely to be responsible for the altered l/k ratios observed. Fig. 5A, 5C ). These cells expressed high levels of surface IgM (in addition to their high cIgM levels), high levels of CD138, intermediate levels of CD19, low levels of B220, and, interestingly, extremely high levels of CD93 (Supplemental Fig. 5B ). This last observation is consistent with a recent report indicating that CD93 is functionally important for plasma cell maintenance (77) . The frequency of IgM 
Altered serum Ab levels and humoral immunity
To assess the in vivo functionality of B cells in IgD a -macroself mice, we first measured their serum Ig levels at 2 mo of age. IgM levels were significantly elevated in IgD a -macroself mice (Fig.  6A) , mirroring the observed increases of splenic cIgM + ASCs in these mice. However, the levels of IgG1 and IgG2a were reduced, and IgG2b showed a slight (although statistically nonsignificant) trend toward reduction. The levels of IgG3 and IgA were similar between the two groups of mice, but IgE was not reliably detectable in either group.
Next, we compared IgD a -macroself to non-Tg littermates for Ab responses to the T cell-independent type 2 (TI-2) Ag TNPFicoll. Measurement of anti-TNP titers of the two isotypes mainly (Fig. 6B) .
To assess TD responses, mice were primed with TNP-Hy in alum and boosted 44 d later with TNP-Hy in buffered saline. Remarkably, the primary responses of IgD a -macroself mice were also higher for IgM but subnormal for IgG1, IgG2a, and IgG2b (Fig. 6C) , resembling their resting serum Ig levels. After secondary challenge, the IgM response remained higher in IgD a -macroself mice, whereas IgG1, IgG2b, and IgA responses were all significantly lower than those of non-Tg mice. Secondary IgG2a and IgE responses were comparable in the two groups. Regardless of isotype, IgD a -macroself mice were clearly capable of mounting a memory response to the secondary challenge that was significantly more robust than their primary response. These findings are consistent with our preliminary studies in which IgD a -macroself mice showed no ill effects to a primary challenge with a sublethal dose of influenza or a secondary challenge with a lethal dose of the same virus (K. Walsh, unpublished observations). Strikingly, primary and secondary anti-TNP responses in IgD a -macroself mice were dominated by Abs carrying l L chains, whereas k + Abs predominated in all responses of control mice (Fig. 6C, (Fig. 7D ), but only a slight and nonstatistically significant reduction of peritoneal B-1 cells (Fig. 7B) . Surface IgD was also downregulated in all compartments tested (Fig. 7C) , and most B cells in the SP were CD93 + (Fig. 7E) . These results thus argue that tolerance mediated by the IgD superantigen can occur in fully mature follicular B cells. (Fig. 8) (Fig. 8B, 8C) . Quantitation of IgM a /IgM b ratios revealed, as expected from the BrdU-labeling analyses, that the (Fig. 8D) .
Rescue of putative preplasma but not mature B cells by Bcl2 Tg
To investigate whether deletion in the IgD a -macroself model involved a Bcl-2-inhibitable pathway, we transferred BM from IgH a mice overexpressing Bcl-2 in the B lineage (Bcl2 Tg) into lethally irradiated wild-type or IgD a -macroself mice and investigated their B cell phenotype. B cells were abundant in IgD a -macroself recipients, but their numbers were still reduced by at least ∼70% in the SP and ∼85% in the LNs (Fig. 9A, Supplemental Table I ). Bcl-2 overexpression only caused an accumulation of CD21
2
CD23
2 CD93 + B cells in the SP, but did not significantly rescue B-2, MZ, or even CD23 + CD93 + B cells (Fig. 9B) . Interestingly, the accumulated CD21 2 CD23 2 cells expressed not only very high levels of CD93 but also CD138 (Fig. 9C) . That these cells did not express high levels of intracellular IgM suggested that they were preplasma cells. However, in contrast to IgD a -macroself mice not overexpressing Bcl-2, which had higher numbers of IgM + ASCs in the SP, enforced Bcl-2 expression did not further increase accumulation of these cells. In fact, the numbers of IgM + ASCs were now comparable between mice that lacked or carried the macroself Ag (Fig. 9D) . Overexpression of Bcl-2 also failed to rescue splenic and LN IgG + CD19 + B cells-by definition, memory B cells (Fig. 9D) . In models of central B cell tolerance, Bcl-2 overexpression improves the efficiency of receptor editing by extending the window of time for secondary gene rearrangements (80) . As expected from our failure to detect induction of RAG expression in SPs of IgD a -macroself mice, overexpression of Bcl-2 did not alter the l/k ratio from the newly formed B cell stage in BM to the more advanced stages in the periphery (Fig. 9E) . Interestingly, B cells in IgD a -macroself mice retained a slightly higher l/k ratio than those in non-Tg mice, but this trend started in the immature stage of the BM.
Accumulation of MZ B cells and plasma cells induced by BAFF overexpression
We generated double Tg mice expressing both IgD a -macroself and BAFF transgenes to assess the effects of BAFF overexpression on B cell tolerance in the IgD a -macroself model. BAFF is an important homeostatic cytokine for follicular, MZ, and plasma B cells that is known to regulate the B cell competition-dependent survival disadvantage of anergic self-reactive B cells (78, 79) . However, its overexpression in the IgD a -macroself mice failed to rescue B-2 cells (Fig. 10A) -macroself mice were increased by nearly 100% (Fig. 10B) , which represented ∼50% of what was found in wild-type mice and ,10% of BAFF single Tgs. In both the SP and LNs, excess BAFF promoted increased numbers of IgM + plasma cells (Fig. 10B, 10C ), but not IgG + ASCs or memory cells (Supplemental Fig. 6A) . Surprisingly, the numbers of CD23 2 and CD23 + transitional B cells were not significantly different among IgD a -macroself mice, regardless of BAFF expression, possibly indicating that they were eliminated prior to acquisition of responsiveness to BAFF. Analysis of BAFF-R(TNFRSF13C) expression in IgD a -macroself mice revealed that MZ and both CD23 2 and CD23 + populations of transitional B cells expressed lower levels than their non-Tg counterparts (Supplemental Fig. 6B ). These results indicate that, unlike models of anergy in which excess BAFF could promote survival of autoreactive B cells, BAFF overexpression in the context of IgD a -macroself Ag merely supports elevated steady-state levels of MZ and IgM + plasma B cells. 
Discussion
IgD a -macroself mice were generated to determine if and how polyclonal B cells can undergo tolerance at a late, post-BM developmental stage. Because IgD itself is a very useful marker for B cell maturity, the effect of IgD a -macroself Ag should by definition be restricted to a B cell that is developmentally advanced. IgD is absent from pre-B cells and is poorly expressed by fraction E immature B cells in the BM and splenic T1 cells (30, 31, 81) . This delayed expression of IgD relative to IgM in turn allowed us to use IgD superantigen to further delineate B cell developmental stages and to test the prediction that self-Ags encountered at a post-BM developmental stage promote deletion or anergy, but not editing.
Studies involving treatment of animals with Abs to Ig constant regions have been instrumental in elucidating precursor/product relationships among naive, immature, and memory B lymphocyte subsets. In the developing chicken, anti-IgM H chain (m-chain) suppression revealed that expression of mIgM preceded in ontogeny the expression of other isotypes because both IgM and IgG isotypes were suppressed (82, 83) . Similar studies in mice supported these results (84-89) and facilitated the discovery of pre-B cells as a population resistant to anti-m treatment that expressed cytoplasmic m (90). Similar studies were carried out using antiIgD treatment in experimental animals (39, (91) (92) (93) (94) (95) (96) (97) (98) (99) (100) (101) (102) (103) (104) . These studies differed in many details, but suggested that anti-IgD treatment could only partly modulate Ab responses, depending upon the context of treatment, the availability of competing, Ab nonreactive B cells, and the type of immunogenic challenge. Moreover, these studies were performed before good markers of B cell subsets were available and before the process of receptor editing was well defined.
Data obtained in the current study support previous tolerance studies using conventional Ig Tg mice, suggesting that IgD can transmit tolerogenic signals (33) and that IgD + cells are largely unable to undergo receptor editing (46, 47, 105) . Infusion of superantigen-carrying cells into intact mice led to deletion of follicular B cells and most MZ B cells, whereas B-1 cell numbers were only slightly affected, suggesting that cells carrying a high level of IgD were eliminated by apoptosis. Remaining splenic B cells had an immature phenotype, including CD93 expression, or were MZ B cells lacking IgD. These phenotypes were similar to those of radiation BM chimeras in which IgD a -superantigen-carrying mice were reconstituted by wild-type IgH a BM, except that B-1 cells were less numerous in BM chimeras. Thus, IgD superantigen can delete preformed follicular and a major subset of MZ B cells, but likely also eliminates their precursors.
Several lines of evidence from the current study indicate that B cells destined for the follicular B cell lineage undergo a developmental block and enhanced turnover at the T1-to-T2 transitional stage, where IgD is highly upregulated (30, 31) . In IgD a -macroself mice, T1 cells are largely spared from deletion, probably because of a lack of sufficient IgD, whereas CD23 + CD93 + transitional cells are reduced in number, increased in turnover rate, and lacked markers associated with phenotype of T2 cells. T2 cells in the SP have been defined as IgM hi CD93 + CD23 + (31) . In the BM of wild-type mice, CD93 + CD23 + T2-like cells are also present, although they appear to be at a slightly earlier transitional stage than splenic T2 cells in that they express significantly lower levels of markers upregulated upon T1-T2 transition, including CD62L, IgD, and CD21 (30, 69) . In IgD a -macroself mice, the remaining CD23 + CD93
+ cells present in the SP have abnormally low levels of CD21 and CD62L, thus exhibiting a phenotype similar to wild-type BM T2-like cells. Splenic T2 cells have been suggested to include a fraction that is proliferative and responsive in particular to BAFF (30, 69, 106, 107 Prolonged exposure to a weakly self-reactive Ag has been shown to result in B cell anergy (109) . Although details differ among the models, a common hallmark of anergic B cells is reduced Ca 2+ signaling in response to IgM cross-linking (72) . The T3 B cell population present in wild-type mice has been suggested to be a collection of anergic B cells also based upon this fact (71 cells (data not shown). Moreover, B-1 and MZ B cells also have higher frequencies of l than do follicular B cells (114, 115) . Without the contribution of follicular cells, which are counterselected in IgD a -macroself mice, the remaining cells are thus enriched in l by selection rather than editing.
The MZ B cell population that develops in IgD a -macroself mice is of interest for several reasons. Normal MZ B cells in rodents may be heterogeneous, including a higher frequency of cells with a fetal-type repertoire (26, (115) (116) (117) . They are believed to derive from a subset of CD23 + CD21
hi cells now termed MZ precursors (118) A most unexpected feature of the IgD a -macroself model was the presence of elevated numbers of IgM + plasma cells. The simplest explanation for their abundance is that in the absence of follicular B cells, the MZ compartment undergoes more TD stimulation and attendant Ab formation, with the aforementioned skewing to the IgM class. Similarly, B-1 responses, which contribute greatly to serum IgM levels, may be enhanced in these mice and preferentially yield IgM responses. The increased numbers of IgM + plasma cells may also be stabilized by a presumed increase in BAFF levels due to a total reduction in B cell numbers in these mice. Consistent with this idea, overexpression of BAFF gives rise to a further increase in their numbers. Serum IgM, but not IgG, from Tg mice also exhibited increased reactivity to dsDNA (data not shown). It remains to be determined whether this reflects abnormal selection events, as this could be a very useful model to study systemic autoimmunity.
